Search - tctmd.com

Displaying 1 - 19 of 19

Sort: Relevancy | Date

News Conference News TCT 2025

PREVUE-VALVE Charts the Prevalence of Valve Disease in the United States

Caitlin E. Cox

October 27, 2025

News Conference News NY Valves 2025

Prompt TAVI Benefits Asymptomatic AS Patients Regardless of Guideline Indication

Todd Neale

June 27, 2025

News Opinion CV Team Dispatch

February 2024 Dispatch for the CV Team

L.A. McKeown

February 01, 2024

News Daily News

ACC’s Valve Staging Tool Reveals Silent Disease is Common in the Elderly

L.A. McKeown

December 22, 2022

News Conference News AHA 2022

Drug Preconditioning Before CABG, Valve Surgery Shows Promise: START

Todd Neale

November 14, 2022

News Daily News

Concerning or Reassuring? Long After COVID-19, CMR Still Yields Clues

Michael O'Riordan

October 03, 2022

News Conference News ESC 2022

CV Care Around Noncardiac Surgery: New ESC Guidelines

Michael O'Riordan

September 07, 2022

News Conference News EuroPCR 2022

Changes in Cardiac Damage After AVR Tied to 2-Year Outcomes

Caitlin E. Cox

May 17, 2022

News Daily News

VISION Eyeballs Too-Low Troponin Values for MI, Injury After Cardiac Surgery

L.A. McKeown

March 04, 2022

News Daily News

Cardiac Abnormalities Seen After COVID-19, but Recovery Is Quick

Michael O'Riordan

January 20, 2022

News Opinion CV Team Dispatch

January 2022 News Roundup

L.A. McKeown

January 01, 2022

News Opinion CV Team Dispatch

March 2021 News Roundup

L.A. McKeown

March 01, 2021

News Daily News

New US Valve Guidance Tackles TAVR vs TAVI, Low-risk AS, Functional MR

Caitlin E. Cox

December 23, 2020

News Conference News TCT 2020

Efficacy Eludes TriGUARD 3 Cerebral Protection Device: REFLECT II

Todd Neale

October 15, 2020

News Daily News

LV Mass Regression After TAVR Linked to Better Long-term Outcomes

Michael O'Riordan

May 13, 2020

News Conference News AHA 2019

Early Surgery Beats a Conservative Approach in Asymptomatic AS: RECOVERY

Yael L. Maxwell

November 16, 2019

News Daily News

Echo Parameters Identify At-Risk Asymptomatic Patients With Severe AS

Michael O'Riordan

October 03, 2018

Presentation TCT 2017

TCT 34: Prediction of Acute Kidney Injury After TAVR by New Biomarkers

Presenter: Reginald I. Low, Michael J. Rinaldi, Mani Arsalan, MD

October 31, 2017

News Industry News

MyoKardia Provides Update on Two Phase 1 Trials of MYK-461 for the Treatment of Hypertrophic Cardiomyopathy

October 07, 2015

Advertisement

PREVUE-VALVE Charts the Prevalence of Valve Disease in the United States

Prompt TAVI Benefits Asymptomatic AS Patients Regardless of Guideline Indication

February 2024 Dispatch for the CV Team

ACC’s Valve Staging Tool Reveals Silent Disease is Common in the Elderly

Drug Preconditioning Before CABG, Valve Surgery Shows Promise: START

Concerning or Reassuring? Long After COVID-19, CMR Still Yields Clues

CV Care Around Noncardiac Surgery: New ESC Guidelines

Changes in Cardiac Damage After AVR Tied to 2-Year Outcomes

VISION Eyeballs Too-Low Troponin Values for MI, Injury After Cardiac Surgery

Cardiac Abnormalities Seen After COVID-19, but Recovery Is Quick

January 2022 News Roundup

March 2021 News Roundup

New US Valve Guidance Tackles TAVR vs TAVI, Low-risk AS, Functional MR

Efficacy Eludes TriGUARD 3 Cerebral Protection Device: REFLECT II

LV Mass Regression After TAVR Linked to Better Long-term Outcomes

Early Surgery Beats a Conservative Approach in Asymptomatic AS: RECOVERY

Echo Parameters Identify At-Risk Asymptomatic Patients With Severe AS

TCT 34: Prediction of Acute Kidney Injury After TAVR by New Biomarkers

MyoKardia Provides Update on Two Phase 1 Trials of MYK-461 for the Treatment of Hypertrophic Cardiomyopathy

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content